Stockscreener 앱 받기
9.85
3.81%
-0.39
시간 외 거래:
9.85
전일 마감가:
$10.24
열려 있는:
$9.86
하루 거래량:
4,701
Relative Volume:
0.01
시가총액:
$62.21M
수익:
$71,000
순이익/손실:
$-2.47M
주가수익비율:
-0.2993
EPS:
-32.9143
순현금흐름:
$-5.24M
1주 성능:
+10.18%
1개월 성능:
-2.09%
6개월 성능:
-25.41%
1년 성능:
-51.39%
1일 변동 폭
$9.85
$10.01
1주일 범위
$8.512
$10.24
52주 변동 폭
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
명칭
Pavmed Inc
전화
(212) 949-4319
주소
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
9.85 | 62.21M | 71,000 | -2.47M | -5.24M | -32.91 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 개시 | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 개시 | Maxim Group | Buy |
Pavmed Inc 주식(PAVM)의 최신 뉴스
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Big Money Moves: Whats next for PAVmed Inc stockBuy Signal & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
PAVM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
PAVmed (PAVM) CEO Lishan Aklog awarded 350,000 restricted shares vesting 2029 - Stock Titan
Craig Kallman (PAVM) holds 384,616 shares, a 6.0% stake in PAVmed - Stock Titan
PAVmed (PAVM) CFO awarded 180,000 restricted shares vesting 2029 - Stock Titan
Director at PAVmed (PAVM) receives 13,930 restricted stock shares - Stock Titan
PAVmed (PAVM) director Timothy Baxter receives 13,930 restricted shares vesting in 2029 - Stock Titan
Restricted stock grant boosts PAVmed (PAVM) director’s holdings - Stock Titan
PAVmed (PAVM) director gets 13,930-share restricted stock grant - Stock Titan
Restricted stock award boosts PAVmed (NASDAQ: PAVM) director stake - Stock Titan
Tasso Partners and Dana Carrera disclose 14.3% stake in PAVmed (PAVM) - Stock Titan
PAVmed (PAVM) general counsel receives 110,000-share restricted award - Stock Titan
PAVmed (PAVM) COO receives 110,000-share restricted stock grant vesting 2029 - Stock Titan
Lucid Diagnostics Inc. (LUCD) stock price, news, quote and history - Yahoo Finance UK
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio - Bitget
PAVmed appoints Joseph Virgilio as medical device chief By Investing.com - Investing.com Australia
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed: Octeris, Inc. Subsidiary Formed to Advance Endoscopic Esophageal Imaging Tech Recently Licensed From Duke University >PAVM - Moomoo
PAVmed appoints Joseph Virgilio as medical device chief - Investing.com
PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill
PAVmed Inc. (NASDAQ:PAVM) Q4 2025 Earnings Call Transcript - Insider Monkey
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Cuts Target Price to $16 - Moomoo
PAVmed Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Fundamentals Check: Is PAVmed Inc a potential multi baggerWeekly Profit Recap & High Conviction Buy Zone Picks - baoquankhu1.vn
PAVmed completes $45M financing, eliminates convertible debt By Investing.com - Investing.com Australia
PAVmed (PAVM) upgraded to buy: Here's what you should know - msn.com
PAVmed Inc (PAVM) Q4 2025 Earnings Call Highlights: Strategic Re - GuruFocus
PAVmed Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:PAVM) 2026-03-30 - Seeking Alpha
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
PAVM: Q4 2025 featured diagnostic revenue growth, a VA contract, and improved non-GAAP loss per share - TradingView
PAVmed Reports 2025 Financial Results, Strengthens Capital Structure, and Expands Medical Device Portfolio Under New Leadership - Minichart
Earnings call transcript: PAVmed Q4 2025 shows restructuring gains By Investing.com - Investing.com India
Earnings call transcript: PAVmed Q4 2025 shows restructuring gains - Investing.com
PAVM: Restructuring and growth initiatives drive commercial momentum and financial stability - TradingView
PAVmed Reports Q4 2025 Financial Results with Key Metrics - Intellectia AI
PAVmed Reports 2025 Results, Strengthens Balance Sheet - TipRanks
Q4 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
PAVmed completes $45M financing, eliminates convertible debt - Investing.com
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
PAVmed (NASDAQ: PAVM) overhauls capital structure and reports 2025 results - Stock Titan
PAVM: Q4 2025 featured capital restructuring, expanded diagnostics, and improved financials - TradingView
PAVmed Q4 2025 Earnings Call Transcript - MarketBeat
PAVmed to Announce Q4 Earnings on March 30 - Intellectia AI
PAVmed Q2 2025 Earnings Preview - MSN
PAVmed Inc. 8-K Filing Details: Company Information, Nasdaq Listing, and 2026 Shareholder Meeting Results - Minichart
PAVmed Inc. 2025 Annual Report: Financials, Risk Factors, and Corporate Governance Overview - Minichart
Bear Alert: Whats next for PAVmed Inc stock2026 Sector Moves & Safe Capital Growth Tips - baoquankhu1.vn
PAVmed's Capital Cleanup Hides High-Reward Catalyst for Patient Biotech Investors - Bitget
PAVmed Shareholders Approve Equity Issuance and Governance Changes - TipRanks
Pavmed Inc (PAVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):